Sovereign Financial Group Inc. Sells 105 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Sovereign Financial Group Inc. decreased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 1.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,711 shares of the financial services provider’s stock after selling 105 shares during the period. Sovereign Financial Group Inc.’s holdings in iShares Biotechnology ETF were worth $832,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. BNP Paribas Financial Markets increased its stake in shares of iShares Biotechnology ETF by 25.7% in the 1st quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock valued at $282,038,000 after acquiring an additional 420,053 shares in the last quarter. Main Management ETF Advisors LLC grew its stake in shares of iShares Biotechnology ETF by 2.6% in the 2nd quarter. Main Management ETF Advisors LLC now owns 578,835 shares of the financial services provider’s stock valued at $79,451,000 after buying an additional 14,535 shares during the period. Global Assets Advisory LLC bought a new stake in iShares Biotechnology ETF in the 1st quarter valued at about $66,059,000. Raymond James Financial Services Advisors Inc. raised its stake in iShares Biotechnology ETF by 24.6% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock worth $29,792,000 after buying an additional 42,822 shares during the period. Finally, Commonwealth Equity Services LLC boosted its holdings in iShares Biotechnology ETF by 5.3% in the first quarter. Commonwealth Equity Services LLC now owns 198,709 shares of the financial services provider’s stock worth $27,267,000 after acquiring an additional 10,033 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $143.00 on Wednesday. The company has a fifty day simple moving average of $145.27 and a 200 day simple moving average of $139.22. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.